"GLIBEMIDE FORTE: Effective Diabetes Control with Dual Action"

May 22, 2024

GLIBEMIDE FORTE 

Glibenclamide (5mg), Metformin HCI (500mg)

Introduction

Glibenclamide (5mg) and Metformin HCI (500mg), marketed as GLIBEMIDE FORTE, is a powerful combination medication used to manage type 2 diabetes. By integrating the insulin-stimulating effects of Glibenclamide with the glucose-lowering action of Metformin, this medication provides an effective solution for controlling blood sugar levels and enhancing overall diabetes management.

Mechanism of Action

Glibenclamide is a sulfonylurea that works by stimulating the pancreas to release more insulin. It binds to specific receptors on pancreatic beta cells, leading to increased insulin secretion. This helps to lower blood glucose levels, particularly after meals.

Metformin primarily works by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues. This dual action helps to reduce fasting and postprandial blood glucose levels. Metformin also helps to reduce the absorption of glucose from the intestines.

Benefits of Combination Therapy

GLIBEMIDE FORTE offers several significant benefits for patients with type 2 diabetes:

  1. Enhanced Glycemic Control: The dual mechanisms of action target different pathways, effectively lowering blood glucose levels and improving HbA1c levels.
  2. Improved Insulin Sensitivity: The combination of Glibenclamide and Metformin improves the body's response to insulin.
  3. Weight Neutrality: While Metformin can aid in weight loss or weight neutrality, Glibenclamide's potential weight gain effect is often offset by Metformin.
  4. Cardiovascular Benefits: Metformin has been shown to provide cardiovascular protection in patients with type 2 diabetes.

Usage and Dosage

The typical dosage of GLIBEMIDE FORTE is one tablet taken once or twice daily, with meals to reduce gastrointestinal side effects. It is important to follow the healthcare provider's instructions and not to adjust the dose without consultation. Regular monitoring of blood glucose levels is essential to ensure optimal diabetes control.

Potential Side Effects

Common side effects may include:

  • Hypoglycemia (low blood sugar)
  • Gastrointestinal issues (e.g., nausea, diarrhea)
  • Weight gain (primarily due to Glibenclamide)
  • Metallic taste (due to Metformin)

Most side effects are mild and transient. However, if any severe or persistent side effects occur, it is essential to consult a healthcare provider immediately.

Conclusion

Glibenclamide (5mg) and Metformin HCI (500mg) (GLIBEMIDE FORTE) is an effective and well-tolerated option for managing type 2 diabetes. This combination therapy provides significant blood sugar control with additional benefits of improved insulin sensitivity and cardiovascular protection. Consult your healthcare provider to determine if this medication is right for your diabetes management.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 

   BUY NOW

 



 

 

 

 

SHARE WITH